" class="no-js "lang="en-US"> N Ragavan - Medtech Alert
Tuesday, May 06, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
N Ragavan

N Ragavan

About N Ragavan

With 30 years of experience, Dr.N. Ragavan is a reputed Urologist in Chennai who believes in providing advanced treatment to his patients. He was first in South India to perform novel and pioneering works in Robotics including Extraperitoneal radical prostatectomy Total Intracorporeal nephroureterectomy , RPLND, Cystectomy with ileal conduit, Boari flap , Culp pyeloplasty and more.

Related Story

Equipment

 First Procedure in Asia-Pacific Performed with Medtronic Hugo ™ Robotic-Assisted Surgery System | Pharmtech Focus

First Procedure in Asia-Pacific Performed with Medtronic Hugo ™ Robotic-Assisted Surgery System

September 27 2021

Medtronic plc (NYSE:MDT) and Apollo Hospitals Group today announced the first clinical procedure in Asia-Pacific with […]